[1]付林杰,唐靖宇,李海志.大剂量氨溴索治疗重症肺炎/呼吸综合窘迫症的循证评价[J].医学信息,2024,37(05):33-37.[doi:10.3969/j.issn.1006-1959.2024.05.005]
　FU Lin-jie,TANG Jing-yu,LI Hai-zhi.Evidence-based Evaluation of High-dose Ambroxol for Severe Pneumonia/Respiratory Distress[J].Journal of Medical Information,2024,37(05):33-37.[doi:10.3969/j.issn.1006-1959.2024.05.005]
点击复制

大剂量氨溴索治疗重症肺炎/呼吸综合窘迫症的循证评价()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年05期
页码:
33-37
栏目:
医学数据科学
出版日期:
2024-03-01

文章信息/Info

Title:
Evidence-based Evaluation of High-dose Ambroxol for Severe Pneumonia/Respiratory Distress
文章编号:
1006-1959（2024）05-0033-05
作者:
付林杰; 唐靖宇; 李海志
（1.云南省阜外心血管病医院药剂科，云南 昆明 650000；2.昆明医科大学药学院，云南 昆明 650000）
Author(s):
FU Lin-jie; TANG Jing-yu; LI Hai-zhi
(1.Department of Pharmacy,Fuwai Yunnan Cardiovascular Hospital,Kunming 650000,Yunnan,China;2.School of Pharmacy,Kunming Medical University,Kunming 650000,Yunnan,China)
关键词:
盐酸氨溴索; 剂量; 重症肺炎; 呼吸综合窘迫症
Keywords:
Ambroxol hydrochloride; Dose; Severe pneumonia; Respiratory distress syndrome
分类号:
R563.1
DOI:
10.3969/j.issn.1006-1959.2024.05.005
文献标志码:
A
摘要:
目的 系统性评价大剂量盐酸氨溴索在临床应用中治疗重症肺炎/呼吸窘迫综合症的有效性和安全性，为临床提供循证药学的参考。方法 计算机检索PubMed、EMbase、Medline、Cochrance Library、中国生物医学文献数据库（CBM）、维普（VIP）、中国知网（CNKI）和万方数据库。收集实验组（成人：1000 mg/d＞日剂量＞90 mg/d；婴儿：100 mg/kg＞日剂量＞30 mg/kg）与对照组（成人和婴儿日剂量均小于实验组最小值范围以下）治疗重症肺炎/呼吸综合窘迫症的安全性、有效性研究。检索时限从建库至2021年9月16日，纳入指标包括：白细胞介素（IL-6）、降钙素原（PCT）、氧合指数（PaO2/FiO2）。用EndNote软件进行文献筛查及管理，提取资料，并按照Jadad量表评价文献质量，采用RevMan5.3软件进行Meta分析，采用漏斗图进行偏倚分析。结果 共纳入10个RCTs，涉及952例患者，其中实验组480例，对照组472例，Jadad评分评价文献质量有3篇为4分，4篇为6分，3篇为1分，纳入的文献质量总体优良。Meta分析显示，实验组在降低IL-6（MD=-0.38，95%CI：-0.44~-0.32，P＜0.000 01）、PCT（MD=-0.47，95%CI：-0.79~-0.15，P=0.004）和升高PaO2/FiO2（MD=5.13，95%CI：2.57~7.68，P＜0.0001）方面优于对照组。结论 大剂量氨溴索治疗重症肺炎/呼吸窘迫综合症可有效降低患者白细胞介素、降钙素原水平，提升其氧合指数，值得临床应用。
Abstract:
Objective To systematically evaluate the efficacy and safety of high-dose ambroxol hydrochloride in the treatment of severe pneumonia/respiratory distress syndrome in clinical application, and to provide evidence-based pharmacy reference for clinical practice.Methods PubMed, EMbase, Medline, Cochrance Library, CBM, VIP, CNKI and Wanfang database were searched by computer. The literature on the safety and effectiveness of the experimental group (adult: 1000 mg/d＞daily dose >90 mg/d; Infant: 100 mg/kg＞daily dose>30 mg/kg) and the control group (adult and infant daily dose were lower than the experimental group) in the treatment of severe pneumonia/respiratory distress syndrome was collected. The retrieval time limit was from the establishment of the database to September 16, 2021. The included indicators included interleukin (IL-6), procalcitonin (PCT), oxygenation index (PaO2/FiO2). EndNote software was used for literature screening and management, data were extracted, and the quality of the literature was evaluated according to the jadad scale. RevMan5.3 software was used for Meta-analysis, and funnel plot was used for bias analysis.Results A total of 10 RCTs with 952 patients were included in this study, including 480 patients in the experimental group and 472 patients in the control group. After evaluation of literature quality using jadad score, 3 articles scored 4 scores, 4 articles scored 6 scores, and 3 articles scored 1 score. Therefore, the quality of the included literatures was generally good. Meta-analysis showed that the experimental group was superior to the control group in reducing IL-6 (MD=-0.38, 95%CI: -0.44 to -0.32, P＜0.000 01), PCT (MD=-0.47, 95%CI: -0.79 to -0.15, P=0.004) and increasing PaO2/FiO2 (MD=5.13, 95%CI: 2.57 to 7.68, P＜0.0001).Conclusion For patients with severe pneumonia/respiratory distress syndrome, high-dose ambroxol can effectively reduce the levels of interleukin and procalcitonin, improve oxygenation index, which is worthy of clinical application.

参考文献/References:

[1]李杨,杨倩.盐酸氨溴索不同剂量及给药方式对呼吸机相关性肺炎患者CPIS评分及炎性因子表达影响[J].中外医学研究,2020,18(17):28-30.[2]刘虎军,高丽萍.不同剂量盐酸氨溴索注射液治疗老年慢性阻塞性肺疾病急性加重期患者对炎性细胞因子的影响[J].昆明医科大学学报,2017,38(9):119-123.[3]吴胜,陆毅.不同剂量盐酸氨溴索治疗NRDS的疗效及其对患者血气指标的影响[J].海南医学,2015,26(2):232-234.[4]岳茂奎,刘芙蓉,赵蕾,等.集束化治疗中/重度急性呼吸窘迫综合征的多中心临床研究[J].中华危重病急救医学,2015(7):601-605.[5]张明虎.不同剂量沐舒坦在急性加重期COPD高龄患者中应用价值的对比研究[J].安徽医药,2014,18(10):1968-1970.[6]王倩,黄江民.不同剂量氨溴索注射液对COPD伴肺部感染患者的疗效[J].辽宁医学杂志,2019,33(6):67-69.[7]Liu Z,Chi J,Feng Z.Observation of curative effect of nasal continuous positive airway pressure combined with high-dose ambroxol for neonatal respiratory failure[J].Pak J Pharm Sci,2018,31(4):1663-1666.[8]Wang D,Sun S,Hu S.The therapeutic efficacy of high-dose ambroxol and the nursing effects in the treatment of severe pneumonia[J].Pak J Pharm Sci,2019,32(3):1409-1413.[9]Baranwal AK,Murthy AS,Singhi SC.High-dose Oral Ambroxol for Early Treatment of Pulmonary Acute Respiratory DistressSyndrome: an Exploratory, Randomized,Controlled Pilot Trial[J].J Trop Pediatr,2015,61(5):339-350.[10]Schmalisch G,Wauer RR,B?觟hme B.Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD)[J].Respir Med,2000,94(4):378-384.[11]Xiang J,Wang P.Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distresssyndrome[J].Exp Ther Med,2019,18(1):654-658.[12]Li Q,Yao G,Zhu X.High-dose ambroxol reduces pulmonary complications in patients with acute cervical spinal cord injury after surgery[J].Neurocrit Care,2012,16(2):267-272.[13]Wauer RR,Schmalisch G,B?觟hme B,et al.Randomized double blind trial of Ambroxol for the treatment of respiratory distress syndrome[J].Eur J Pediatr,1992,151(5):357-363. [14]Romanini BM,Sandri MG,Tosi M,et al.Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery[J].Int J Clin Pharmacol Res,1986,6(2):123-127. [15]陈浩.大剂量盐酸氨溴索联合纤维支气管镜灌洗治疗老年重症肺炎的疗效和安全性分析[J].黑龙江医学,2015,39(3):243-244.[16]王婷婷,陈钰清,江炳源,等.大剂量盐酸氨溴索联合纤维支气管镜灌洗对老年重症肺炎疗效及肺功能分析[J].中外医学研究,2020,18(21):42-44.[17]陈绵聪,陈伟,林秀山,等.大剂量盐酸氨溴索联合纤支镜灌洗对老年重症肺炎患者氧合指数血清 CRP、PCT水平的影响[J].河北医学,2020,26(9):1434-1438.[18]吴忠焕,林亚发,吴清松,等.不同剂量的盐酸氨溴索对成人重症肺炎的影响及对患者血清CD40L、FPG水平的作用[J].中华保健医学杂志,2023,25(3):342-343.[19]陆鹏,张凡,周中标,等.支气管镜肺泡灌洗联合不同剂量氨溴索注射液对重症肺炎患者呼吸功能、炎性因子、血管内皮功能的影响[J].解放军医药杂志,2022,34(1):65-68.[20]周利华,洪海玲,童童.不同剂量氨溴索联合阿奇霉素对肺炎支原体肺炎患儿免疫功能和血清促炎因子水平的影响[J].中国妇幼保健,2023,38(4):657-660.

相似文献/References:

[1]许雪花,刘华之,张凤英,等.盐酸氨溴索氧气驱动雾化吸入在甲状腺术后咳痰困难的 疗效观察[J].医学信息,2018,31(11):135.[doi:10.3969/j.issn.1006-1959.2018.11.043]
　XU Xue-hua,LIU Hua-zhi,ZHANG Feng-ying,et al.Effect of Oxygen Atomization Inhalation of Ambroxol Hydrochloride on Postoperative Difficulty of Expectoration after Thyroidectomy[J].Journal of Medical Information,2018,31(05):135.[doi:10.3969/j.issn.1006-1959.2018.11.043]
[2]张 燕,王永娟.舒芬太尼复合地佐辛用于痔上黏膜环切术后自控镇痛的剂量分析[J].医学信息,2019,32(04):140.[doi:10.3969/j.issn.1006-1959.2019.04.045]
　ZHANG Yan,WANG Yong-juan.Dose Analysis of Sufentanil Combined with Dizocine for Self-controlled Analgesia after Supraorbital Mucosal Circumcision[J].Journal of Medical Information,2019,32(05):140.[doi:10.3969/j.issn.1006-1959.2019.04.045]
[3]李安辉,邹 庆,李沛云,等.盐酸氨溴索联合盐酸丙卡特罗治疗小儿肺炎的效果分析[J].医学信息,2019,32(10):151.[doi:10.3969/j.issn.1006-1959.2019.10.050]
　LI An-hui,ZOU Qing,LI Pei-yun,et al.Effect Analysis of Ambroxol Hydrochloride Combined with Procaterol Hydrochloride in the Treatment of Infantile Pneumonia[J].Journal of Medical Information,2019,32(05):151.[doi:10.3969/j.issn.1006-1959.2019.10.050]
[4]陶雪莹,岑 超,何俐莹.盐酸氨溴索联合通窍鼻炎颗粒治疗幼儿分泌性中耳炎的临床效果[J].医学信息,2019,32(20):145.[doi:10.3969/j.issn.1006-1959.2019.20.045]
　TAO Xue-ying,CEN Chao,HE Li-ying.Clinical Effect of Ambroxol Hydrochloride Combined with Tongqiao Rhinitis Granules in the Treatment of Secretory Otitis Media in Children[J].Journal of Medical Information,2019,32(05):145.[doi:10.3969/j.issn.1006-1959.2019.20.045]
[5]钟红燕.盐酸氨溴索治疗慢阻肺合并肺部感染的临床效果[J].医学信息,2019,32(12):154.[doi:10.3969/j.issn.1006-1959.2019.12.051]
　ZHONG Hong-yan.Clinical Effect of Ambroxol Hydrochloride in the Treatment of Chronic Obstructive Pulmonary Disease with Pulmonary Infection[J].Journal of Medical Information,2019,32(05):154.[doi:10.3969/j.issn.1006-1959.2019.12.051]
[6]郑婵娟.盐酸氨溴索注射液联合酚妥拉明注射液治疗 小儿重症肺炎的疗效[J].医学信息,2019,32(16):136.[doi:10.3969/j.issn.1006-1959.2019.16.045]
　ZHENG Chan-juan.Efficacy of Ambroxol Hydrochloride Injection Combined with Phentolamine Injection in the Treatment of Severe Pneumonia in Children[J].Journal of Medical Information,2019,32(05):136.[doi:10.3969/j.issn.1006-1959.2019.16.045]
[7]任雨欣.盐酸氨溴索联合二羟丙茶碱对煤工尘肺合并COPD的疗效[J].医学信息,2020,33(03):140.[doi:10.3969/j.issn.1006-1959.2020.03.044]
　REN Yu-xin.Efficacy of Ambroxol Hydrochloride Combined with Dihydroxyprophylline on Coal Workers’ Pneumoconiosis with COPD[J].Journal of Medical Information,2020,33(05):140.[doi:10.3969/j.issn.1006-1959.2020.03.044]
[8]王岳宸.盐酸氨溴索联合N-乙酰半胱氨酸治疗老年COPD的效果及对患者血清VAP-1、SFRP-1、ECP水平的影响[J].医学信息,2021,34(10):110.[doi:10.3969/j.issn.1006-1959.2021.10.030]
　WANG Yue-chen.The Effect of Ambroxol Hydrochloride Combined with N-acetylcysteine in the Treatment of COPD in the Elderly and Its Effect on Patients’ Serum VAP-1,SFRP-1 and ECP Levels[J].Journal of Medical Information,2021,34(05):110.[doi:10.3969/j.issn.1006-1959.2021.10.030]
[9]高 山.盐酸氨溴索治疗老年慢阻肺合并肺部感染临床效果[J].医学信息,2021,34(11):158.[doi:10.3969/j.issn.1006-1959.2021.11.044]
　GAO Shan.Clinical Effect of Ambroxol Hydrochloride in the Treatment of Elderly Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Infection[J].Journal of Medical Information,2021,34(05):158.[doi:10.3969/j.issn.1006-1959.2021.11.044]
[10]郑合清.盐酸氨溴索联合纤维支气管镜吸痰对老年肺炎的疗效及安全性[J].医学信息,2021,34(14):154.[doi:10.3969/j.issn.1006-1959.2021.14.043]
　ZHENG He-qing.Efficacy and Safety of Ambroxol Hydrochloride Combined with Fiberoptic Bronchoscopy for Sputum Suction in Elderly Patients with Pneumonia[J].Journal of Medical Information,2021,34(05):154.[doi:10.3969/j.issn.1006-1959.2021.14.043]

更新日期/Last Update: 1900-01-01